Medesis Pharma S.A. (EPA:ALMDP)
France flag France · Delayed Price · Currency is EUR
0.3500
0.00 (0.00%)
Inactive · Last trade price on May 14, 2025

Revance Therapeutics Revenue

Medesis Pharma had revenue of 31.15K EUR in the half year ending June 30, 2024, a decrease of -13.10%. This brings the company's revenue in the last twelve months to 63.64K, down -85.17% year-over-year. In the year 2023, Medesis Pharma had annual revenue of 300.03K with 52.07% growth.

Revenue (ttm)
63.64K
Revenue Growth
-85.17%
P/S Ratio
27.83
Revenue / Employee
6.36K
Employees
10
Market Cap
1.77M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2023300.03K102.74K52.07%
Dec 31, 2022197.30K101.57K106.10%
Dec 31, 202195.73K-112.77K-54.09%
Dec 31, 2020208.50K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition